We are live on
!
Find out more
TRCT
Tower Research Capital (TRC) Portfolio holdings
AUM
$4.08B
1-Year Est. Return
58.77%
This Fund
S&P 500
This Quarter
Est. Return
-4.46%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$10.5B
AUM Growth
+$4.68B
(+81%)
Cap. Flow
+$4.98B
Cap. Flow
% of AUM
47.59%
Top 10 Holdings %
Top 10 Hldgs %
29.39%
Holding
7,240
New
774
Increased
2,864
Reduced
2,421
Closed
823
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$413M |
| 2 |
Microsoft
MSFT
|
+$342M |
| 3 |
Amazon
AMZN
|
+$210M |
| 4 |
Tesla
TSLA
|
+$130M |
| 5 |
NVIDIA
NVDA
|
+$126M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$51.9M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$45.1M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$34.7M |
| 4 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$27.3M |
| 5 |
iShares Russell 1000 ETF
IWB
|
+$11.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.51% |
| 2 | Consumer Discretionary | 11.81% |
| 3 | Healthcare | 9.9% |
| 4 | Communication Services | 9.49% |
| 5 | Financials | 9.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CNSY
4476
Cerenome, Inc. Common Stock
CNSY
$25.3M
| $9K | ﹤0.01% |
+25
| New | +$9.51K |
|
4477
PIMCO Corporate & Income Opportunity Fund
PTY
$2.49B
| $9K | ﹤0.01% |
+578
| New | +$8.9K |
|
4478
PubMatic
PUBM
$801M
| $9K | ﹤0.01% |
337
-270
| -44% | -$6.92K |
|
|
AIXC
4479
AIxCrypto Holdings Inc
AIXC
$13.7M
| $9K | ﹤0.01% |
+27
| New | +$10.5K |
|
|
RC
4480
Ready Capital
RC
$306M
| $9K | ﹤0.01% |
583
-5
| -0.9% | -$75 |
|
4481
REX American Resources
REX
$1.47B
| $9K | ﹤0.01% |
534
-22,554
| -98% | -$365K |
|
4482
Rallybio
RLYB
$90.2M
| $9K | ﹤0.01% |
164
-165
| -50% | -$13.7K |
|
4483
RenovoRx
RNXT
$63.1M
| $9K | ﹤0.01% |
3,076
+2,185
| +245% | +$7.65K |
|
4484
Safe Bulkers
SB
$789M
| $9K | ﹤0.01% |
1,739
-880
| -34% | -$3.59K |
|
4485
SI-BONE Inc
SIBN
$848M
| $9K | ﹤0.01% |
405
-16
| -4% | -$332 |
|
4486
Credit Suisse X-Links Silver Shares Covered Call ETNs due April 21 2033
SLVO
$12.5M
| $9K | ﹤0.01% |
+86
| New | +$8.88K |
|
|
SMLR
4487
DELISTED
Semler Scientific
SMLR
| $9K | ﹤0.01% |
186
+83
| +81% | +$5.56K |
|
4488
Sanara MedTech
SMTI
$314M
| $9K | ﹤0.01% |
310
+260
| +520% | +$6.59K |
|
4489
Scorpio Tankers
STNG
$3.98B
| $9K | ﹤0.01% |
413
-1,454
| -78% | -$23.2K |
|
4490
Stereotaxis
STXS
$137M
| $9K | ﹤0.01% |
2,315
+1,226
| +113% | +$5.79K |
|
4491
Smith & Wesson
SWBI
$643M
| $9K | ﹤0.01% |
576
-8,011
| -93% | -$135K |
|
4492
Transact Technologies
TACT
$53.2M
| $9K | ﹤0.01% |
1,403
+798
| +132% | +$7.09K |
|
|
TBI
4493
Trueblue
TBI
$311M
| $9K | ﹤0.01% |
328
-1,757
| -84% | -$48.3K |
|
4494
TriCo Bancshares
TCBK
$1.84B
| $9K | ﹤0.01% |
231
-264
| -53% | -$11.4K |
|
4495
Talphera
TLPH
$63.8M
| $9K | ﹤0.01% |
1,596
+975
| +157% | +$8.25K |
|
4496
Transmedics
TMDX
$3.07B
| $9K | ﹤0.01% |
339
-1,843
| -84% | -$33K |
|
4497
ReposiTrak
TRAK
$155M
| $9K | ﹤0.01% |
1,787
+1,136
| +175% | +$7.23K |
|
4498
ProShares Ultra Gold
UGL
$801M
| $9K | ﹤0.01% |
536
| – | – |
|
4499
UroGen Pharma
URGN
$2.35B
| $9K | ﹤0.01% |
1,089
-1,116
| -51% | -$8.7K |
|
|
VERO
4500
DELISTED
Venus Concept
VERO
| $9K | ﹤0.01% |
+37
| New | +$9.37K |
|
Similar funds
CA
AP
BWA
JSW
GCM
ZP
GCM
USCWA
Tower Research Capital (TRC)'s Q1 2022 Portfolio in Review
As of Q1 2022, Tower Research Capital (TRC) held 7,240 positions worth $10.5B, up 81% from $5.78B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Tower Research Capital (TRC) deployed $4.98B of net new capital in Q1 2022, opening 774 new positions and adding to 2,864 existing holdings. Its largest new stake was iShares MSCI USA Value Factor ETF: 132,204 shares worth $13.8M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 25% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $45.1M trimmed.
- Tower Research Capital (TRC)'s largest Q1 2022 buy was iShares MSCI USA Value Factor ETF: 132,204 shares worth $13.8M.
- Tower Research Capital (TRC) added most to Apple in Q1 2022, an estimated $413M increase.
- Tower Research Capital (TRC)'s biggest Q1 2022 reduction was iShares Russell 2000 ETF, cutting an estimated $45.1M.
- Tower Research Capital (TRC) fully exited State Street Technology Select Sector SPDR ETF in Q1 2022, selling an estimated $51.9M.
- Tower Research Capital (TRC)'s ten largest holdings make up 29% of its $10.5B portfolio in Q1 2022.
- Tower Research Capital (TRC) opened 774 new positions and closed 823 in Q1 2022.
- Tower Research Capital (TRC)'s portfolio value rose 81% quarter-over-quarter to $10.5B.
Based on Tower Research Capital (TRC)'s 13F filing for Q1 2022, filed 12 May 2022.